Abstract
The invention relates to a paralytic peptide for neuromuscular therapy and other uses requiring disruption of neuromuscular mechanisms.
| Original language | English |
|---|---|
| Patent number | EP1601691 |
| IPC | PCT/CA2003/001749 |
| Publication status | Published - 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cell Neurochemistry
Fingerprint
Dive into the research topics of 'Shrew Paralytic Peptide For Use In Neuromuscular Therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver